Etirinotecan pegol in women with recurrent platinum-resistant or refractory ovarian cancer.
Bardhi E, Marchetti C, Scopelliti A, Musacchio L, Tomao F, Schiavi M, Carraro C, Palaia I, Monti M, Muzii L, Benedetti Panici P.
Bardhi E, et al. Among authors: carraro c.
Expert Opin Investig Drugs. 2019 Aug;28(8):667-673. doi: 10.1080/13543784.2019.1648430. Epub 2019 Jul 30.
Expert Opin Investig Drugs. 2019.
PMID: 31353973
Review.